Home > Drug Search >
  • Targets: P-Glycoprotein (P-gp)
  •   > 
Drug Filter
Category:
chemistry (19) biology (27)
Status:
Approved (5) Withdrawn (1) Phase Ⅲ (9) Phase Ⅱ (14) Phase Ⅰ (16)
Clinical Stage:
Pending (2) Active (26) Discontinued (12)
Bio-Type:
CAR T cell therapy (14) Bispecific antibody (3) Whole antibody (4) ADC (4)
Company:
Concert (1) GlaxoSmithKline (1) Horizon (1) Janssen (2) Lilly (1) MedImmune (1) National Cancer Institute (3) Novartis (3) Otsuka (1) Dana-Farber Cancer Institute (1) Pfizer (1) Novelion Therapeutics (1) Sanofi (1) Seattle Genetics (2) Servier (1) UCB (1) Vertex (3) Ziopharm Oncology (1) Xencor (2) University of Texas Southwestern Medical Center (1) Unknown (1) Cabaret Biotech (1) Kite Pharma (2) Juno Therapeutics (3) Fred Hutchinson Cancer Research Center (3) Seattle Children's Research Institute (3) TaKaRa Bio (1) Atara Biotherapeutics (1) Cellectis (1) bluebird bio (1) Baylor College of Medicine (2) Texas Children's Hospital (2) Methodist Hospital System (2) Christie Hospital NHS Foundation Trust (1) Cellular Therapeutics (1) Intrexon Corporation (1) University of Minnesota (1) ADC Therapeutics (1) Affimed (1) Huons (1) Galileo Research (1) Ontogen (1) Oxis International (1) Debiopharm Group (1) Mundi Pharma (1) University of Pennsylvania (2) MacroGenics (1) MorphoSys (1) CBA (1) Xenova (2) Kanisa (1) Memorial Sloan-Kettering Cancer Center (5) M.D. Anderson Cancer Center (1) Neuraltus Pharmaceuticals (1) ImmunoGen (1) Amgen (1) Bayer (1) Celgene (4)
Indication:
Acute lymphoblastic leukaemia (ALL) (13) Acute myeloid Leukemia (AML) (2) Atrial flutter (2) Breast cancer (3) Chronic lymphocytic leukemia (CLL) (6) Cystic fibrosis (CF) (1) Dry eye disease (1) Follicular lymphoma (3) EBV-associated post-transplant lymphoproliferative disease (PTLD) (1) Leukemia (5) Lung cancer (1) Lymphoma (1) Malignancies (1) Mantle cell lymphoma (MCL) (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (3) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (9) Ovarian cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (6) Systemic lupus erythematosus (1) Ventricular arrhythmias (2) Supraventricular arrhythmias (2) B-cell lymphoma (4) Autoimmune diseases (1) B-cell malignancies (1) Skin irritations (1) Diffuse large B cell lymphoma (7) Bacterial infection (1) Diabetic neuropathy (1) hematological malignancies (1) Agitation in patients with Alzheimer's disease (1) Neuromyelitis optica (NMO) (1) Scleroderma (1)
Aprv. Year:
2012 (1) 2014 (1) 2017 (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top